| Drug Name: | Tiagabine (115103-54-3) |
|---|---|
| PubChem ID: | 60648 |
| SMILES: | CC1=C(SC=C1)C(=CCCN2CCC[C@H](C2)C(=O)O)C3=C(C=CS3)C |
| InchiKey: | PBJUNZJWGZTSKL-MRXNPFEDSA-N |
| Therapeutic Category: | Anticonvulsants, Central Nervous System Agents, GABA Agents, GABA Agonists, Membrane Transport Modulators, Neurotransmitter Agents, Neurotransmitter Uptake Inhibitors |
| Molecular Weight (dalton) | : | 375.559 |
| LogP | : | 5.04484 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 4 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 40.54 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category